USP37P1

Across TCGA pan-cancer cohorts, USP37P1 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated USP37P1 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher USP37P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated USP37P1 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

UCEC, PAAD, and UVM are the cancer types where USP37P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	II,III,IV	0.206	0.825	<.001	66	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.556	.014	36	view →
UVM	OS	Tertile	All	0.249	0.712	.033	18	view →
ESCA	OS	Tertile	III,IV	1.000	0.374	.043	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

USP37P1–UCEC (DFS)

Open the UCEC breakdown →